光子计数CT影像组学特征的稳健性:辐射剂量与虚拟单能重建的影响及与双能CT的比较
在模拟肝、肾、椎体的腹部体模上,光子计数CT于四个剂量水平(1、3、6、12 mGy)行40-100 keV虚拟单能重建,并与匹配剂量的双能CT(80/140 kVp)比较影像组学特征可重复性;肝在所有剂量下ICC/CCC>0.96,肾在1 mGy最佳而椎体在12 mGy最佳,肝在70-80 keV可重复性最优。
要点
- 肝脏影像组学在光子计数CT所有剂量下均稳健(ICC/CCC>0.96),6 mGy时达峰(ICC=0.992,CCC=0.998)。
- 肾脏可重复性随剂量升高而下降,1 mGy时最优(ICC=0.783,CCC=0.858)。
- 椎体在12 mGy可重复性更优(ICC=0.631,CCC=0.859),1和3 mGy因部分容积效应ICC<0.60。
核心结论
- 光子计数CT对均匀组织(肝)在所有剂量下均可实现稳健影像组学,而不均匀区域(肾、椎体)需能量与剂量优化方案;肾影像组学的剂量-可重复性反向关系凸显光子计数CT在低剂量成像中的独特光谱优势;作者主张临床采用光子计数CT并标准化协议以获得可靠、剂量高效的影像组学生物标志物。
研究设计与样本
- 体模研究:使用模拟肝、肾、椎体组织的人体腹部体模(Kyoto Kagaku CTU-41),在光子计数CT系统上以四个剂量水平(1、3、6、12 mGy)行40-100 keV虚拟单能重建,双能CT(80/140 kVp)在匹配剂量下作为对照,使用PyRadiomics从标准化ROI提取影像组学特征。
关键影像表现/征象
- 肝在所有剂量下ICC/CCC>0.96,6 mGy时最稳定(ICC=0.992,CCC=0.998),44.75%的特征CV≤10%。
- 肾可重复性随剂量升高而降低,1 mGy时最优(ICC=0.783,CCC=0.858)。
- 椎体在12 mGy可重复性更优(ICC=0.631,CCC=0.859),1 mGy和3 mGy因部分容积效应一致性较低(ICC<0.60)。
- 肝在70-80 keV可重复性最优(ICC/CCC≈1.00),低变异(CV>20%:35.24-38.10%)。
- 肾在70-80 keV一致性高(ICC>0.993,CCC>0.997),持续存在变异(CV>20%:52.38-68.57%)。
诊断标准与关键数值
- 可重复性以组内相关系数(ICC)、一致性相关系数(CCC)和变异系数(CV<10%)量化。
- 肝在所有剂量下ICC/CCC>0.96,6 mGy时ICC=0.992、CCC=0.998,44.75%特征CV≤10%。
- 肾1 mGy时ICC=0.783、CCC=0.858;椎体12 mGy时ICC=0.631、CCC=0.859,1和3 mGy时ICC<0.60。
- 肝70-80 keV时ICC/CCC≈1.00,CV>20%特征占35.24-38.10%;肾70-80 keV时ICC>0.993、CCC>0.997,CV>20%特征占52.38-68.57%。
临床应用与阅片要点
- 作者主张临床采用光子计数CT并标准化协议以获得可靠、剂量高效的影像组学生物标志物;对不均匀区域(肾、椎体)需能量与剂量优化方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of Virtual Monoenergetic Image (VMI) reconstructions and radiation dose on radiomic feature reproducibility in photon-counting CT (PCCT) and compare its performance with dual-energy CT (DE-CT).
METHODS: An anthropomorphic abdominal phantom (Kyoto Kagaku CTU-41) simulating liver, kidney, and vertebral tissues was scanned on a PCCT system at four dose levels (1, 3, 6, 12 mGy) with VMI reconstructions (40-100 keV). DE-CT acquisitions (80/140 kVp) at matched doses served as the comparator. Radiomic features were extracted from standardized ROIs using PyRadiomics. Reproducibility was quantified via intraclass correlation coefficient (ICC), concordance correlation coefficient (CCC), and coefficient of variation (CV < 10 %).
RESULTS: Demonstrated exceptional reproducibility across all doses (ICC/CCC > 0.96) for liver, with peak stability at 6 mGy (ICC = 0.992, CCC = 0.998) and 44.75 % of features achieving CV ≤ 10 %. Kidneys exhibited inverse dose-reproducibility relationships, with optimal stability at 1 mGy (ICC = 0.783, CCC = 0.858). Vertebrae achieved superior reproducibility at 12 mGy (ICC = 0.631, CCC = 0.859), while 1 mGy and 3 mGy showed lower agreement (ICC < 0.60) due to partial volume effects.Liver radiomics showed superior reproducibility at 70-80 keV (ICC/CCC ≈1.00) and low variability (CV>20 %: 35.24-38.10 %). For Kidneys, high consistency was achieved at 70-80 keV (ICC>0.993, CCC>0.997) and persistent variability (CV>20 %: 52.38-68.57 %).
CONCLUSION: PCCT enables robust radiomics for homogeneous tissues (liver) across all doses, while heterogeneous regions (kidney, vertebrae) require energy- and dose-optimized protocols. The inverse dose-reproducibility relationship in renal radiomics highlights PCCT's unique spectral advantages for low-dose imaging. These findings advocate for clinical adoption of PCCT with protocol standardization to unlock reliable, dose-efficient radiomic biomarkers.
引用
- Mao H, Feng T, Lv S, et al. Robustness of radiomic features in photon-counting CT: Impact of radiation dose and virtual monoenergetic reconstructions compared to dual-energy CT. Eur J Radiol. 2025. PMID: 40554944. doi:10.1016/j.ejrad.2025.112257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。